# Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

> **NCT05257460** · NA · COMPLETED · sponsor: **University of Cambridge** · enrollment: 28 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Hybrid closed-loop using ultra-rapid insulin lispro
- **DEVICE:** Hybrid closed-loop using standard insulin lispro

## Key facts

- **NCT ID:** NCT05257460
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-25
- **Primary completion:** 2022-12-28
- **Final completion:** 2023-03-25
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257460, "Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05257460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*